Earnings Preview: Precision BioSciences
Portfolio Pulse from Benzinga Insights
Precision BioSciences (NASDAQ:DTIL) is scheduled to release its quarterly earnings report on March 27, 2024, with an expected EPS of $-2.05. The company's past earnings performance shows a history of beating EPS estimates, which has occasionally led to positive stock price movements the following day. However, the stock has experienced a 44.55% decline over the last 52 weeks. Investors are looking for not just an earnings beat but also positive guidance for future growth.
March 26, 2024 | 5:01 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Precision BioSciences is expected to report an EPS of $-2.05 for the upcoming quarter. Historical data shows the company has a track record of beating EPS estimates, which sometimes leads to positive stock movements. However, the stock has been down 44.55% over the past year.
Precision BioSciences has a history of beating EPS estimates, which could lead to positive short-term stock movements if the trend continues. However, the significant yearly decline in stock price and the overall negative sentiment may temper any potential gains. The key factor to watch will be the company's future guidance, as it can significantly influence investor sentiment and stock price.
CONFIDENCE 80
IMPORTANCE 90
RELEVANCE 100